Phase
Condition
Hemorrhage
Treatment
EmboCube Embolization Gelatin
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥18 years
Subject requires embolization and is suitable for treatment with EmboCube inaccordance with device Instructions For Use for the treatment of bleeding orhemorrhage.
Subject provides written informed consent to study data collection.
Exclusion
Exclusion Criteria:
Bleeding site in the neck, head, or brain.
Subject has co-morbidity with survival prognosis of less than 30 days, in theopinion of the treating physician
In the investigator's opinion, participation in the study may not be in thesubject's best interest.
Study Design
Connect with a study center
Chris O'Brien Lifehouse
Camperdown, New South Wales 2050
AustraliaSite Not Available
South Western Sydney Local Health District
Liverpool,
AustraliaSite Not Available
Alfred Health
Sydney,
AustraliaSite Not Available
Centre Hospitalier Universitaire de Nîmes - Caremeau
Nîmes,
FranceSite Not Available
HEGP
Paris,
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.